sodium ozagrel

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
02419922018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We investigated the neuroprotective properties of single doses of minocycline and ozagrel when administered prior to stroke. Male… (More)
Is this relevant?
2010
2010
Sodium ozagrel (SO) prevents platelet aggregation and vasoconstriction in the cerebral ischemia. It plays an important role in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
BACKGROUND Edaravone, a free radical scavenger approved by the Japanese Ministry of Health, Labor and Welfare in 2001 for… (More)
Is this relevant?
2009
2009
This study was aimed to investigate the incidence of thrombosis in patients with primary thrombocytosis (PT) and its correlation… (More)
Is this relevant?
2007
2007
The aim of the study was to investigate the influence of sodium ozagrel on CYP2D6 (cytochromeP450 2D6) activity. The studies were… (More)
Is this relevant?
2003
2003
Sodium ozagrel (ozagrel), a selective thromboxane A2 synthetase inhibitor, has been used for the treatment of various types of… (More)
Is this relevant?
2002
2002
We reported a 31 year-old man with repeated episodes of migraine at a frequency of about once a week on and after January, 2000… (More)
Is this relevant?
2000
2000
GPIIb/IIIa antagonists are expected to have a beneficial effect on acute cerebral infarction, however, the occurrence of… (More)
Is this relevant?
1996
1996
The present study was designed to examine the effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar… (More)
Is this relevant?
1995
1995
To investigate the effectiveness of thromboxane (Tx) synthase inhibitor in the prevention of experimental hepatic metastasis, an… (More)
Is this relevant?